EPISODE · Apr 16, 2026 · 20 MIN
The Risk Pharma Refuses to Model
from My Pharma Reviews · host Salil Kallianpur
Over the past decade, China has reduced its exposure to US government debt from ~$1.3 trillion to under $700 billion while steadily accumulating gold. Not as a trade. Not as a hedge. But as a statement on geopolitics. When war broke out in Ukraine, the West froze a large portion of Russia’s reserves and fundamentally changed how sovereign nations think about risk. Suddenly, “safe assets” carried political conditions. And diversification became less about yield and more about control.Gold, in that context, is not just a commodity. It is neutral. It cannot be sanctioned, frozen, or weaponized. But let’s not overstate the shift. The US dollar, backed by the scale and depth of United States markets, still anchors the global financial system. There is no real substitute yet. This is de-risking, not de-dollarization. The dollar is not likely to collapse, but a parallel system will rise. One where countries hedge their dependence, build alternative rails, and prepare for a world where finance and geopolitics are no longer separable. There it is not about what is the safest asset? It is about what is beyond control? Why not cryptocurrency? That’s for another episode.Further reading is encouraged. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit mypharmareviews.substack.com
Embed this episode
Ready to play
The Risk Pharma Refuses to Model
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.